Block

NEW

PAYER, PROVIDERS AND PHARMACIES

HEALTHCARE

PHARMA

We Answer the “What” and the “Why” of

Market Access.

LET'S TALK

Solutions for Pharmaceutical Manufacturers

Our customers rely on our industry-leading data and insights and cutting-edge technology to overcome barriers to access.

LEARN MORE

Solutions for
Healthcare IT

Let our unbeatable covered lives methodology and innovative technology inform your market access strategy.

LEARN MORE

Solutions for Payers, Providers and Pharmacies

Establish reimbursement policies, formulary positioning and access financial assistance that make therapies affordable for patients.

LEARN MORE

New Solution Highlights

We analyze market access trends and market readiness challenges while providing brand and market access solutions to navigate the changing healthcare market.

LEARN MORE

Slide 1

Insights

Unleash the Power of Real-World Data

MMIT helps pharma companies harness the power of real world data to better understand the patient journey.

LEARN MORE

Slide 1

Press Release

MMIT Wins Titan Health Award for Healthcare Innovation

Patient Access Analytics received the Gold Award for Technology Solutions in Healthcare.

Slide 1

Real-World Data

Overcoming the Chasm Between Payer Policy and Real-Life Practice

Integrated RWD from claims, labs, and other sources is instrumental to a successful market access strategy. This executive summary of a BioPharma Dive webinar explains how RWD helps manufacturers uncover and resolve patient access barriers.

DOWNLOAD

Slide 1

Insights

Intelligent Insights

Our Zitter Insights Panel uses research to illuminate the complexities of market access.

LEARN MORE

Block

Meet the expert

Decisions in a Dash: Informing Your Commercial Strategy in Near Real Time

December 5, 2023 | 1:00pm EST

Whether new clinical results support your brand or a new competitor is challenging it, rapid turn-around market research can help enhance manufacturers’ understanding of key market events or unexpected changes in the market.

Days

Hours

Minutes

Seconds

Slide 1

Industry Leading Insights

MMIT offers a range of publications for pharma, payers and providers covering news, strategy and insights across the spectrum. Our in-house journalism division AIS Health provides objective news and analysis of industry trends while RJ Health provides a comprehensive look at industry updates as they apply to medically covered drug reimbursement processes.

Slide 5

"We need doctors to fight the good fight so that any patient who needs the therapy can get the therapy, and MMIT plays a key role in that process. We need you to help us fulfill our mission for our patients."

Vice President of Market Access

Small Pharma Company

Slide 2

"As a small company, we appreciate the flexibility and responsiveness of the MMIT team. Their customer support team has done a great job working with our new hires to get them trained on their solutions."

Mark Devlin

Vice President, Head of Market Access | Phathom Pharmaceuticals

Slide 1

“Ryan [Witherington] and the team at MMIT have been great partners in our initiatives to analyze and communicate payer policy data for our product through innovative field tools, both MMIT-developed and developed by us using MMIT data. FormTrak Web, in particular, has been well-received by our field sales team and we are excited to transition to FormTrak in Veeva to streamline the process and make it an even more valuable tool.”

Director of Market Access

Large Pharma Company

Slide 3

“DHP provided us a list that was stronger than what we typically begin with, which, in turn, lowered the amount of time spent on payer that didn’t fit our profile.”

Erin Studstill

Vice President of Operations and Technology | MarketLauncher

Slide 4

"Throughout my 10 years in market access, I've been exposed to most of the top solutions, at times simultaneously. I've always found myself turning to MMIT because of their products' ease of use and data integrity."

Jai Persico

National Account Executive | Neurocrine Biosciences

TL 5

Thought Leadership

Humira Biosimilars: Pricing, Contracting and Interchangeability

AbbVie’s blockbuster drug Humira, an injectable used to treat a range of inflammatory conditions, saw the end of its 20-year, $200 billion monopoly in January.

TL 1

Thought Leadership

Under Pressure, Payers Are Reevaluating Prior Authorizations

For decades, payers have used prior authorizations (PA) with the intent of curbing costs by preventing the unnecessary use of medical procedures or treatments.

TL 2

Thought Leadership

Four Trends That Are Shaping the Future of Market Access

Stakeholders have had to adjust to new developments in the healthcare ecosystem such as the Inflation Reduction Act and the recent ruling that insurers can no longer implement copay accumulator adjustor programs, among many others.

TL 3

Thought Leadership

Payer Coverage of Fast-Tracked Therapies: A Cautionary Tale

When a pharma company secures expedited approval for a drug in development, everyone involved is usually thrilled. After all, a faster approval process means that patients in need will be able to access this critical treatment more quickly.

TL 4

Thought Leadership

Why Updated Health Plan Enrollment Data Is Crucial in the Wake of Medicaid Changes

Due to the end of the public health emergency for COVID-19 and subsequent redeterminations for Medicaid, health plan enrollment data has become increasingly volatile.

why-updated-health-plan-enrollment-data-is-crucial-featured-image

TL 6

Thought Leadership

What Pharma Needs From RWD: Top 5 Trends

Many larger manufacturers with their own teams of data analysts have been using RWD for years, smaller manufacturers are just beginning to incorporate RWD into their clinical development and market access strategies.

What-Pharma-Needs-From-RWD-featured-image

Subscribe to MMIT's Thought Leadership

Get the latest from MMIT’s leading subject matter experts, receiving the latest posts right to your inbox. Top-quality thought leadership 100% free.

subscribe today

News and Media

Drug Channels

Press Release

MMIT Wins Titan Health Award for Healthcare Innovation

December 4, 2023

Patient Access Analytics received the Gold Award for Technology Solutions in Healthcare.

Drug Channels

How Payers Are Reacting To Insulin Price Changes

September 15, 2023

Insulin price caps and list price reductions are a huge step forward for patient access. But what will these changes mean for health plans?

Contract Pharma

Solving Pharma’s Underlying Rebate Leakage Problem

September 13, 2023

Rebate leakage drains millions in revenue from pharma companies every year. To ensure contract compliance, manufacturers can implement these five steps.

Drug Channels

ICER Review Leads to Formulary Changes

September 13, 2023

Buy-and-bill remains the most common distribution channel for provider-administered oncology drugs, but pharmacy channels are still significant, especially for hospital outpatient departments.

STAT

Uncovering The Patient Journey: Four Ways Real-World Data Offers Value

September 12, 2023

Infusing a commercialization strategy with real-world data provides a more holistic view of the patient journey.

Modern Healthcare

Helping payers and providers grow amid volatility: Leveraging data to improve the care experience

July 1, 2023

Preliminary data indicate that 2023 may prove to be the most volatile year for health plan enrollment in a decade.

Biopharma Dive

BioPharma Dive

Pfizer’s RSV Vaccine Wins FDA Approval in Older Adults

May 31, 2023

The shot’s clearance comes several weeks after the regulator made GSK’s Arexvy the first vaccine for RSV in the U.S.

BioPharma Dive

How Real-World Data Helps Manufacturers See the Complete Market Access Story

May 15, 2023

Over the past few decades, pharma companies have perfected the art of using market access data to support product launches, negotiate payer discounts, and secure preferred status and positioning.

Consumer Affairs

Can Anything Be Done to Bring Down Prescription Drug Costs?

May 5, 2023

The Senate Health, Education, Labor and Pensions (HELP) Committee went to work this week to find a bipartisan consensus on measures to reduce prescription drug costs.

Pharmacy Times

Pharamacy Times

Adult Vaccinations and Decentralization of Health Care: How to Navigate the Landscape

May 5, 2023

Vaccination is especially important for older adults with any chronic health conditions because vaccines can prevent serious illness and resulting complications down the road.

Press Release

MMIT Announces Winners of the Eighth-Annual Specialty Pharmacy Patient Choice Awards

May 4, 2023

Four leading specialty pharmacies honored for their dedication to the highest quality customer service.

Drug Channels

Press Release

MMIT Announces Finalists of the Eighth-Annual Specialty Pharmacy Patient Choice Awards

April 11, 2023

Twelve specialty pharmacies recognized for their dedication to top-quality customer service.

Press Release

Drug Channels

Key Trends in Medical Benefit Contracting and Value-Based Agreements

April 7, 2023

In recent years, the rising cost of specialty pharmaceuticals has motivated payers to implement tighter restrictions and seek both traditional and value-based contracts with manufacturers.

Press Release

MMIT Announces the Winners of the Q4 2022 Patient Access Awards

March 30, 2023

Payers and physicians recognize manufacturers across seven therapeutic areas who are dedicated to smoothing patient access.

Fierce Healthcare

Staying Competitive in an Expanding Medicare Advantage Market

March 13, 2023

By the end of 2023, more than half of the total Medicare population is expected to be enrolled in Medicare Advantage (MA), which has climbed from 25.2 million members in 2020 to 31.5 million members today.

Drug Channels

Copay Accumulator and Maximizer Update: Adoption Plateaus as Insurers Battle Patients Over Copay Support

February 22, 2023

Our latest update finds that for 2022, about 40% of commercial lives have adopted these benefit designs.

Healthline

Biosimilar Drugs to Humira Are Arriving: Why Prices Won't Be Significantly Lower

February 3, 2023

Humira, the best-selling drug used to treat multiple forms of arthritis and other conditions such as ulcerative colitis and Crohn’s disease, finally has some competition.